ODTX
Odyssey Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$28.76
+8.94%Institutional positioning
13F filings over the trailing two quarters
New 58Increased 0Reduced 0Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| FMR LLC | New Position | 5,179,262 | Aug 13, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | New Position | 3,794,883 | Aug 12, 2026 |
| TPG GP A, LLC | New Position | 3,690,146 | Aug 14, 2026 |
| Lightspeed Management Company, L.L.C. | New Position | 3,608,443 | Aug 14, 2026 |
| ORBIMED ADVISORS LLC | New Position | 3,001,198 | Aug 14, 2026 |
| Sanofi | New Position | 1,991,918 | Jul 28, 2026 |
| DEERFIELD MANAGEMENT COMPANY, L.P. | New Position | 1,046,139 | Aug 14, 2026 |
| Sands Capital Alternatives, LLC | New Position | 875,000 | Aug 13, 2026 |
| HHLR ADVISORS, LTD. | New Position | 831,656 | Aug 14, 2026 |
| General Catalyst Group Management, LLC | New Position | 810,272 | Aug 17, 2026 |
| Affinity Asset Advisors, LLC | New Position | 766,346 | Aug 13, 2026 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | New Position | 725,000 | Aug 14, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 720,440 | Aug 13, 2026 |
| Foresite Capital Management V, LLC | New Position | 713,105 | Aug 14, 2026 |
| Vivo Capital, LLC | New Position | 575,000 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings